http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080052545-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4119e5119c286e2462f662fc023527e7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate | 2006-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbc2bce944db3b3bc24d9fe1b191738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72b98f1f7d70c0af10b355d9aa248a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c0cfaea0a5d63a140f9951ca0febe60 |
| publicationDate | 2008-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080052545-A |
| titleOfInvention | Polyclonal Antisera against Universal Tumor Antigen |
| abstract | The present invention provides a method for producing an in vivo humoral response to embryonic tissue in (i) a non-human vertebrate, wherein said embryonic tissue is tissue of the same genetic line as a non-human vertebrate. ; (ii) recovering from the immunized non-human animal spleen and separating each spleen cell / lymphocyte from the spleen; (iii) inducing a second in vivo humoral response to the isolated spleen cell / lymphocyte suspension obtained in step (ii) in a further non-human animal of the same genetic line as the non-human animal of step (i) ; And (iv) isolating polyclonal antiserum against a universal tumor antigen, which is obtainable by isolating a desired polyclonal antiserum from said animal. The present invention also provides the use of polyclonal antisera for the manufacture of pharmaceutical compositions for the improvement, prevention and / or treatment of cancer, in particular breast cancer, lung cancer, prostate cancer, uterine cancer, colon cancer, gastric cancer or bladder cancer. The invention also relates to the use of the polyclonal serum of the invention for the preparation of a pharmaceutical composition, wherein said pharmaceutical composition is administered to a subject in need of treatment in combination with an additional anti-proliferative drug or medicament. Will be. |
| priorityDate | 2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.